RHIANNA FAGAN: Open Payments
NPI 1265296263 · ST JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,181 in 199 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,260 · 2025 $4,181
Food & beverage: $4,181
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 20 | $591 |
| Janssen Biotech, Inc. | 28 | $591 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $465 |
| ABBVIE INC. | 25 | $445 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $439 |
| Ardelyx, Inc. | 12 | $226 |
| Lilly USA, LLC | 10 | $211 |
| GENZYME CORPORATION | 9 | $196 |
| Regeneron Healthcare Solutions, Inc. | 8 | $184 |
| QOL Medical, LLC | 7 | $182 |
Products named: REZDIFFRA, TREMFYA, XIFAXAN, DUPIXENT, ENTYVIO, IBSRELA, LINZESS, OMVOH.
Industry payments across FL — which companies pay providers there.
